Evaluation of the pharmacological effects and exploration of the mechanism of traditional Chinese medicine preparation Ciwujia tablets in treating insomnia based on ethology, energy metabolism, and urine metabolomic approaches.
Study Design
- 研究タイプ
- preclinical animal study
- 介入
- Evaluation of the pharmacological effects and exploration of the mechanism of traditional Chinese medicine preparation Ciwujia tablets in treating insomnia based on ethology, energy metabolism, and ur not specified (multiple doses likely tested)
- 比較対照
- Placebo
- 効果の方向
- Positive
- バイアスリスク
- Unclear
Abstract
Ciwujia Tablets (CWT) are produced by concentrating and drying the extract solution of the dried rhizome of Eleutherococcus senticosus (Rupr. & Maxim.) Maxim [Araliaceae; E. senticosus radix et rhizoma]. Besides, CWT is included in the 2020 edition of Chinese Pharmacopoeia and is widely used in the treatment of insomnia. It mainly contains eleutheroside B, eleutheroside E, isofraxidin, eleutheroside C, ciwujiatone, and chlorogenic acid, as well as other chemical components. Although the clinical efficacy of CWT in treating insomnia has been confirmed, its functions and pharmacological effects have not been systematically evaluated and its mechanism of action in the treatment of insomnia remains unclear. Therefore, in this study, behavioral, energy metabolism, and metabonomics methods were applied to systematically evaluate the effect of CWT on insomnia. Additionally, urine metabonomics based on UPLC-Q-TOF-MS/MS were utilized to identify potential endogenous biomarkers of insomnia, detect the various changes before and after CWT treatment, explore the metabolic pathway and potential target of CWT, and reveal its pharmacological mechanism. Results revealed that CWT increased inhibitory neurotransmitter (5-HT and GABA) content and reduced the content of excitatory neurotransmitters (DA and NE). Moreover, CWT enhanced autonomous behavioral activity, stabilized emotions, and promoted the return of daily basic metabolic indexes of insomniac rats to normal levels. The urine metabolomics experiment identified 28 potential endogenous biomarkers, such as allysine, 7,8-dihydroneopterin, 5-phosphonooxy-L-lysine, and N-acetylserotonin. After CWT treatment, the content of 22 biomarkers returned to normal levels. The representative markers included N-acetylserotonin, serotonin, N-methyltryptamine, and 6-hydroxymelatonin. Additionally, the metabolic pathways in rats were significantly reversed, such as tryptophan metabolism, folate biosynthesis, phenylalanine metabolism, and tyrosine metabolism. Ultimately, it is concluded that CWT regulated tryptophan metabolism, folate biosynthesis, phenylalanine metabolism, and other metabolic levels in the body. This drug has been confirmed to be effective in the treatment of insomnia by regulating the content of serotonin, 6-hydroxymelatonin, N-acetylserotonin, and N-methyltryptamine to a stable and normal level in tryptophan metabolism.
Full Text
Figures
FIGURE 1
Conceptual diagram summarizing the relationship between evaluation of the pharmacological effects and exploration of the mechanism of traditional Chinese medicine preparation Ciwujia tablets in treating insomnia based on ethology, energy metabolism, and urine metabolomic approaches and the biological processes described in this research.
diagram
FIGURE 2
Visual summary of the pathways and interactions relevant to evaluation of the pharmacological effects and exploration of the mechanism of traditional Chinese medicine preparation Ciwujia tablets in treating insomnia based on ethology, energy metabolism, and urine metabolomic approaches, as discussed in the context of ciwujia Tablets (CWT) are produced by concentrating and drying the extract solution of the dried rhizome of Eleuthero.
diagram
FIGURE 3
Schematic representation highlighting the mechanisms underlying evaluation of the pharmacological effects and exploration of the mechanism of traditional Chinese medicine preparation Ciwujia tablets in treating insomnia based on ethology, energy metabolism, and urine metabolomic approaches and their potential therapeutic implications.
diagram
FIGURE 4
Diagram illustrating the key biological concepts related to evaluation of the pharmacological effects and exploration of the mechanism of traditional Chinese medicine preparation Ciwujia tablets in treating insomnia based on ethology, energy metabolism, and urine metabolomic approaches, synthesizing evidence presented in the study.
diagram
FIGURE 5
Illustrative overview of the mechanisms involved in evaluation of the pharmacological effects and exploration of the mechanism of traditional Chinese medicine preparation Ciwujia tablets in treating insomnia based on ethology, energy metabolism, and urine metabolomic approaches, depicting key molecular and cellular pathways.
diagram
FIGURE 6
Conceptual diagram summarizing the relationship between evaluation of the pharmacological effects and exploration of the mechanism of traditional Chinese medicine preparation Ciwujia tablets in treating insomnia based on ethology, energy metabolism, and urine metabolomic approaches and the biological processes described in this research.
diagram
FIGURE 7
Visual summary of the pathways and interactions relevant to evaluation of the pharmacological effects and exploration of the mechanism of traditional Chinese medicine preparation Ciwujia tablets in treating insomnia based on ethology, energy metabolism, and urine metabolomic approaches, as discussed in the context of ciwujia Tablets (CWT) are produced by concentrating and drying the extract solution of the dried rhizome of Eleuthero.
diagram
FIGURE 8
Schematic representation highlighting the mechanisms underlying evaluation of the pharmacological effects and exploration of the mechanism of traditional Chinese medicine preparation Ciwujia tablets in treating insomnia based on ethology, energy metabolism, and urine metabolomic approaches and their potential therapeutic implications.
diagram
FIGURE 9
Diagram illustrating the key biological concepts related to evaluation of the pharmacological effects and exploration of the mechanism of traditional Chinese medicine preparation Ciwujia tablets in treating insomnia based on ethology, energy metabolism, and urine metabolomic approaches, synthesizing evidence presented in the study.
diagram
FIGURE 10
Illustrative overview of the mechanisms involved in evaluation of the pharmacological effects and exploration of the mechanism of traditional Chinese medicine preparation Ciwujia tablets in treating insomnia based on ethology, energy metabolism, and urine metabolomic approaches, depicting key molecular and cellular pathways.
diagram
FIGURE 11
Conceptual diagram summarizing the relationship between evaluation of the pharmacological effects and exploration of the mechanism of traditional Chinese medicine preparation Ciwujia tablets in treating insomnia based on ethology, energy metabolism, and urine metabolomic approaches and the biological processes described in this research.
diagram
FIGURE 12
Visual summary of the pathways and interactions relevant to evaluation of the pharmacological effects and exploration of the mechanism of traditional Chinese medicine preparation Ciwujia tablets in treating insomnia based on ethology, energy metabolism, and urine metabolomic approaches, as discussed in the context of ciwujia Tablets (CWT) are produced by concentrating and drying the extract solution of the dried rhizome of Eleuthero.
diagramTables
TABLE 1
| No. | Rt min | M/Z determined | M/Z calculated | Ion species | Scan mode | Proposed composition | Postulated identity | Change trend |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.72 | 168.0633 | 145.1629 | [M + Na]+ | ESI+ | C6H11NO3 | Allysine | ↑ |
| 2 | 0.85 | 252.0502 | 207.1825 | [M + FA-H]- | ESI- | C10H9NO4 | 4-(2-Aminophenyl)-2,4-dioxobutanoic acid | ↓ |
| 3 | 0.87 | 259.0939 | 129.1153 | [2M + H]+ | ESI+ | C5H7NO3 | 1-Pyrroline-4-hydroxy-2-carboxylate | ↓ |
| 4 | 0.94 | 256.1051 | 255.2314 | [M + H]+ | ESI+ | C9H13N5O4 | 7,8-Dihydroneopterin | ↑ |
| 5 | 0.96 | 287.0662 | 242.1728 | [M + FA-H]- | ESI- | C6H15N2O6P | 5-phosphonooxy-L-lysine | ↓ |
| 6 | 1.78 | 259.1661 | 129.1673 | [2M + H]+ | ESI+ | C6H11NO2 | Pipecolic acid | ↓ |
| 7 | 1.79 | 263.1029 | 218.2538 | [M + FA-H]- | ESI- | C12H14N2O2 | N-Acetylserotonin | ↑ |
| 8 | 2.08 | 240.1105 | 239.2304 | [M + H]+ | ESI+ | C9H13N5O3 | Dihydrobiopterin | ↑ |
| 9 | 2.20 | 207.0631 | 184.1902 | [M + Na]+ | ESI+ | C9H12O4 | Vanylglycol | ↓ |
| 10 | 2.83 | 177.0567 | 176.2148 | [M + H]+ | ESI+ | C10H12N2O | Serotonin | ↓ |
| 11 | 3.41 | 137.0601 | 136.1504 | [M + H]+ | ESI+ | C8H8O2 | 4-Hydroxyphenylacetaldehyde | ↓ |
| 12 | 3.68 | 261.1317 | 130.1308 | [2M + H]+ | ESI+ | C6H10O3 | Ketoleucine | ↑ |
| 13 | 3.76 | 160.0778 | 137.1182 | [M + Na]+ | ESI+ | C8H11NO | Tyramine | ↓ |
| 14 | 4.03 | 198.1136 | 197.2338 | [M + H]+ | ESI+ | C10H15NO3 | Metanephrine | ↓ |
| 15 | 4.20 | 202.0467 | 179.1705 | [M + Na]+ | ESI+ | C9H9NO3 | Hippuric acid | ↑ |
| 16 | 4.22 | 307.1663 | 153.1803 | [2M + H]+ | ESI+ | C8H11NO2 | Dopamine | ↓ |
| 17 | 4.66 | 377.1463 | 376.4024 | [M + H]+ | ESI+ | C17H20N4O6 | Riboflavin | ↓ |
| 18 | 4.75 | 301.2132 | 278.4107 | [M + Na]+ | ESI+ | C18H30O2 | Alpha-Linolenic acid | ↓ |
| 19 | 4.81 | 175.1239 | 174.2416 | [M + H]+ | ESI+ | C11H14N2 | N-Methyltryptamine | ↓ |
| 20 | 5.42 | 293.1470 | 146.1407 | [2M + H]+ | ESI+ | C5H10N2O3 | L-Glutamine | ↑ |
| 21 | 5.58 | 323.1464 | 161.1638 | [2M + H]+ | ESI+ | C6H11NO4 | Aminoadipic acid | ↑ |
| 22 | 5.82 | 249.1236 | 248.2849 | [M + H]+ | ESI+ | C13H16N2O3 | 6-Hydroxymelatonin | ↑ |
| 23 | 6.13 | 241.1700 | 121.1862 | [2M-H]- | ESI- | C8H11N | 1-Phenylethylamine | ↑ |
| 24 | 6.17 | 144.0778 | 121.1862 | [M + Na]+ | ESI+ | C8H11N | Phenylethylamine | ↑ |
| 25 | 6.46 | 227.2026 | 228.3716 | [M + H]+ | ESI- | C14H28O2 | Myristic acid | ↑ |
| 26 | 7.00 | 269.0790 | 224.2104 | [M + FA-H]- | ESI- | C10H12N2O4 | L-3-Hydroxykynurenine | ↑ |
| 27 | 7.34 | 286.1145 | 241.2531 | [M + FA-H]- | ESI- | C9H15N5O3 | Tetrahydrobiopterin | ↑ |
| 28 | 9.78 | 277.2173 | 276.4016 | [M + H]+ | ESI+ | C18H28O2 | Stearidonic acid | ↑ |
TABLE 2
| No. | Pathway name | Biomarker matching quantity | |
|---|---|---|---|
| CWT | Diazepam | ||
| 1 | Lysine degradation | 4 | 2 |
| 2 | Tryptophan metabolism | 4 | 1 |
| 3 | Folate biosynthesis | 3 | 3 |
| 4 | Phenylalanine metabolism | 2 | 1 |
| 5 | Tyrosine metabolism | 3 | 3 |
| 6 | Riboflavin metabolism | 1 | 0 |
| 7 | D-Glutamine and D-glutamate metabolism | 1 | 1 |
| 8 | Nitrogen metabolism | 1 | 1 |
| 9 | Valine, leucine, and isoleucine biosynthesis | 1 | 1 |
| 10 | alpha-Linolenic acid metabolism | 1 | 0 |
| 11 | Arginine biosynthesis | 1 | 1 |
| 12 | Alanine, aspartate, and glutamate metabolism | 1 | 1 |
| 13 | Glyoxylate and dicarboxylate metabolism | 1 | 1 |
| 14 | Biosynthesis of unsaturated fatty acids | 1 | 0 |
| 15 | Pyrimidine metabolism | 1 | 1 |
| 16 | Valine, leucine, and isoleucine degradation | 1 | 1 |
| 17 | Fatty acid biosynthesis | 1 | 1 |
| 18 | Aminoacyl-tRNA biosynthesis | 1 | 1 |
| 19 | Purine metabolism | 1 | 1 |
References
- Impact of a Nordic diet on psychological function in young students Nutr. Health, 2021
- Validation of the thyrotoxicosis-associated insomnia model induced by thyroxine through sympathetic stimulation: Face, construct and predictive perspectives Exp. Neurobiol., 2021
- Phytochemistry and pharmacology of Celastrus paniculatus wild.: A nootropic drug J. Complement. Integr. Med., 2021
- Sleep and eating disorders Curr. Psychiatry Rep., 2016
- Local melatonin regulates inflammation resolution: A common factor in neurodegenerative, psychiatric and systemic inflammatory disorders CNS Neurol. Disord. Drug Targets, 2014
- The expanded biology of serotonin Annu. Rev. Med., 2009
- α-Adrenergic receptor function, arousal and sleep: Mechanisms and therapeutic implications Pharmacopsychiatry, 2012
- Open-field behavior of house mice selectively bred for high voluntary wheel-running Behav. Genet., 2001
- Untitled Insomnia. JAMA., 2013
- Is metabolic rate increased in insomnia disorder? A systematic review Front. Endocrinol., 2018
- Probable insomnia is associated with future total energy intake and diet quality in men Am. J. Clin. Nutr., 2016
- Untitled Pharmacopeia of the people’s Republic of China, 2020
- Omega-3 long-chain polyunsaturated fatty acid and sleep: A systematic review and meta-analysis of randomized controlled trials and longitudinal studies Nutr. Rev., 2021
- Catechol-O-methyltransferase, dopamine, and sleep-wake regulation Sleep. Med. Rev., 2015
- Poor sleep quality and sleep apnea are associated with higher resting energy expenditure in obese individuals with short sleep duration J. Clin. Endocrinol. Metab., 2012
- Insomnia overview: Epidemiology, pathophysiology, diagnosis and monitoring, and nonpharmacologic therapy Am. J. Manag. Care, 2020
- Clinical efficacy of neurometabolic therapy of dissomical disorders in asthenic syndrome Zh. Nevrol. Psikhiatr. Im. S. S. Korsakova, 2019
- 5-HT-moduline controls serotonergic activity: Implication in neuroimmune reciprocal regulation mechanisms Prog. Neurobiol., 2000
- Autonomic dysregulation and sleep homeostasis in insomnia Sleep, 2021
- Functional metabolomics decipher biochemical functions and associated mechanisms underlie small-molecule metabolism Mass Spectrom. Rev., 2020
- Ziziphus jujuba mill. Var. spinosa (bunge) Hu ex H. F. Chou seed ameliorates insomnia in rats by regulating metabolomics and intestinal flora composition Front. Pharmacol., 2021
- Insomnia and risk of cardiovascular disease Chest, 2017
- Influence of tryptophan and serotonin on mood and cognition with a possible role of the gut-brain Axis Nutrients, 2016
- A review of Acanthopanax senticosus (Rupr and Maxim.) harms: From ethnopharmacological use to modern application J. Ethnopharmacol., 2021
- How important is tryptophan in human health? Crit. Rev. Food Sci. Nutr., 2019
- GABA and l-theanine mixture decreases sleep latency and improves NREM sleep Pharm. Biol., 2019
- Neuroprotective effects of Eleutherococcus senticosus bark on transient global cerebral ischemia in rats J. Ethnopharmacol., 2012
- Exploring potential mechanism of ciwujia tablets for insomnia by UPLC-Q-TOF-MS/MS, network pharmacology, and experimental validation Front. Pharmacol., 2022
- Protective effect of extract of Acanthopanax senticosus Harms on dopaminergic neurons in Parkinson's disease mice Phytomedicine, 2012
- Tryptophan and kynurenine levels and its association with sleep, nonphysical fatigue, and depression in chronic hemodialysis patients J. Ren. Nutr., 2017
- Anxiolytic effects of acanthopanax senticosus HARMS occur via regulation of autonomic function and activate hippocampal BDNF⁻TrkB signaling Molecules, 2018
- Serotonin control of sleep-wake behavior Sleep. Med. Rev., 2011
- Metabolomics and metabolic diseases: Where do we stand? Cell Metab., 2017
- Traditional use of Chinese herbal medicine for insomnia and priorities setting of future clinical research J. Altern. Complement. Med., 2019
- The serotonergic raphe promote sleep in zebrafish and mice Neuron, 2019
- Dose translation from animal to human studies revisited FASEB J., 2008
- Identification of bioactive metabolites using activity metabolomics Nat. Rev. Mol. Cell Biol., 2019
- Formosan wood mice (Apodemus semotus) exhibit more exploratory behaviors and central dopaminergic activities than C57BL/6 mice in the open field test Chin. J. Physiol., 2020
- Lilium davidii extract alleviates p-chlorophenylalanine-induced insomnia in rats through modification of the hypothalamic-related neurotransmitters, melatonin and homeostasis of the hypothalamic-pituitary-adrenal axis Pharm. Biol., 2020
- Treatment of insomnia with traditional Chinese herbal medicine Int. Rev. Neurobiol., 2017
- Tryptophan supplementation modulates social behavior: A review Neurosci. Biobehav. Rev., 2016
- Insomnia Ann. Intern. Med., 2021
- Sleep, sleep deprivation, autonomic nervous system and cardiovascular diseases Neurosci. Biobehav. Rev., 2017
- The serotonin transporter gene-linked polymorphic region (5-HTTLPR) and the sleep-promoting effects of tryptophan: A randomized placebo-controlled crossover study J. Psychopharmacol., 2019
- Integration of lipidomics and metabolomics for in-depth understanding of cellular mechanism and disease progression J. Genet. Genomics, 2020
- Mass spectrometry-based serum lipidomics strategy to explore the mechanism of Eleutherococcus senticosus (Rupr. & Maxim.) Maxim. leaves in the treatment of ischemic stroke Food Funct., 2021
- Untitled Experimental methodology of Pharmacology, 2022
- Armillaria mellea fermentation liquor ameliorates p-chlorophenylalanine-induced insomnia associated with the modulation of serotonergic system and gut microbiota in rats J. Food Biochem., 2022
- The effect of raising and lowering tryptophan levels on human mood and social behaviour Philos. Trans. R. Soc. Lond. B Biol. Sci., 2013
- Influence of warm acupuncture on gut microbiota and metabolites in rats with insomnia induced by PCPA PLoS One, 2022
- Metabolic flexibility during sleep Sci. Rep., 2021
- Effects of acanthopanax senticosus on brain injury induced by simulated spatial radiation in mouse model based on pharmacokinetics and comparative proteomics Int. J. Mol. Sci., 2018
- Sleep and diet: Mounting evidence of a cyclical relationship Annu. Rev. Nutr., 2021
Used In Evidence Reviews
Similar Papers
Journal of sleep research · 2017
European guideline for the diagnosis and treatment of insomnia.
Chronobiology international · 2012
Circadian typology: a comprehensive review.
Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2017
Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline.
Movement disorders : official journal of the Movement Disorder Society · 2011
The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease.
Cell · 1981
Regulation of terminal differentiation of cultured human keratinocytes by vitamin A.
Journal of neuroendocrinology · 2003